Greater Barcelona Metropolitan Area
CEO with 25+ years of experience in in-vitro diagnostics, with a mission to detect neurodegenerative diseases and cancer at their earliest, most treatable stages. A highly adaptable Neuroscientist and healthcare executive dedicated to introducing new technology and services into healthcare. Significant experience working with diverse individuals and teams from around the world including Europe, The US, Latin America, and Asia. Embracing AI in day-to-day work and motivated by the huge potential that AI offers to improve health outcomes and involve individuals much more in maximizing their health span. A broad breadth and depth of experience in strategy, business development and start-ups, including management, internationalization, IP, R&D, funding and licensing. A strong negotiator and bilingual communicator. Love adapting technical and scientific information into messages that others can understand, value and identify with. We have only begun to scratch the surface of what is possible in the pursuit of human health and happiness.
The early diagnosis of Alzheimer´s Disease.
Conducted Ultra Hi-plex enzyme activity analysis to uncover disease mechanisms, focusing on metabolic diseases. Spearheaded early commercial growth initiatives in Spain for REACTOMIX SL. Developed expertise in enzyme analysis, disease understanding, and commercial expansion strategies.
Responsable for all aspects of Business Development Activity as well as Strategic Planning. Additional responsibilities include Commercialization in the US.
Responsible for Corporate Business Development and the The Americas and The UK for a leading global cardiac genomics company. Key responsibility is the commercialization of proprietary, innovative product portfolio. Management of P&L. Key role in strategic business development for both genomics and POC proteomics.